News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Virostat Inc. Release: New Monoclonal Antibodies To Mumps Virus


4/17/2014 1:28:09 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

April 17, 2014 -- Mumps virus is a common childhood disease that is highly contagious. Transmission is by aerosol and direct contact.

Symptoms include swelling of the salivary and parotid glands. It is a vaccine-preventable disease, however recent outbreaks have occurred in the US due to unvaccinated clusters.

ViroStat has released 3 NEW monoclonal antibodies to this virus. They are specific to the highly conserved and abundant nucleoprotein (NP). These new antibodies function in ELISA and IFA and serve as excellent research tools.

Contact ViroStat at 207-856-6620 for additional information or download the data sheet at: www.virostat-inc.com ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies, supplying researchers and manufacturers since 1985. Specialties include high affinity antibodies to Flu A, Flu B, RSV & Strep A for use in rapid lateral flow devices as well as antibodies to food-borne pathogens and toxins. Also, many specificities to HCV, HBV, CMV & EBV for use in anti-viral HTS assays

ViroStat, Inc.
PO Box 8522
Portland, ME 04104 USA
Phone: 207-856-6620
Fax: 207-856-6864
E-mail: info@virostat-inc.com
Web: www.virostat-inc.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES